Development

As a European CDMO, Synerlab dedicate specific resources to development for their clients. Thanks to a research and development center with proven competences in drug formulation, expertise in galenics and analytics and phase 1 to 3 production of clinical batches.

Pharmaceutical development is a major business unit of Synerlab Group

Being able to bring to market new treatments is a major challenge for pharmaceutical firms. Among the different stages of pharmaceutical development, that of formulation more and more associated with specific processes requires agility and expert skillset. Some majors in the industry tend to outsource development as of the formulation stage in order to maximize their success as act faster. Thanks to long lasting client relations, a real asset in terms of pharmaceutical development, Synerlab Group can offer a complete expertise from formulation to industrialaisation, including issuing clinical batches in diverse areas (new chemical entities, OTC, freeze dried products, liquid sterile non injectables).

Thanks to a specialised development center with a proven experience in producing liquid and solid clinical batches and one in servicing analytical and regulatory requirements, completed by a unique expertise in specific niche technical processes such as freeze drying and liquid sterile non injectables, Synerlab Group is able to offer a diverse and global development set of services.

Because of this very diversity, Synerlab Group have created the right synergies for cross fertilization of savoir faires and capacity through a project based approach of different dossiers. Inspired by best practices, they offer guarantees of a robust solution servicing development demands through to industrialisation phase.